2 February 2009, London, UK, and Cambridge, MA: Antisoma plc (LSE: ASM; USOTC:
ATSMY) announces that Daniel Elger, VP Marketing & Communications, will present
an overview of the Company's strategy, programmes and prospects at the 12th
Annual BIO CEO & Investor Conference in New York on Monday, 8th February at
8:30am EST/1:30pm GMT.


A webcast of the presentation will be available on Antisoma's website at


http://www.antisoma.com/asm/media/webcast/


For live viewing of the webcast, it is recommended that viewers log on 15
minutes early in order to register and download any necessary software.


Enquiries:

Alison Saville

Senior Marketing and Communications Executive

Antisoma plc

+44 (0)20 3249 2144


Background on Antisoma

Antisoma is a London Stock Exchange-listed biopharmaceutical company that
develops novel products for the treatment of cancer. The Company has operations
in the UK and the US. Please visit www.antisoma.com <

http://www.antisoma.com>
for further information about Antisoma.



[HUG#1379580]